These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38215035)

  • 21. Adjuvant chemotherapy in stage IB neuroendocrine small cell carcinoma of the cervix.
    Abulafia O; Sherer DM
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):740-4. PubMed ID: 7572111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of postoperative radiotherapy and analysis of prognostic factors in early-stage neuroendocrine carcinoma of cervix].
    Song XC; Zhang H; Zhong S; Tan XJ; Ma SQ; Jin Y; Pan LY; Wu M; Cao DY; Yang JX; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2023 Sep; 58(9):680-690. PubMed ID: 37724385
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
    Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
    Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
    Zhou J; Yang HY; Wu SG; He ZY; Lin HX; Sun JY; Li Q; Guo ZW
    Cancer Med; 2016 Jun; 5(6):1108-15. PubMed ID: 26990881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
    Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
    Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.
    Lan-Fang L; Hai-Yan S; Zuo-Ming Y; Jian-Qing Z; Ya-Qing C
    Eur J Gynaecol Oncol; 2012; 33(1):68-73. PubMed ID: 22439409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
    Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
    Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
    Cattrini C; Cerbone L; Rubagotti A; Zinoli L; Latocca MM; Messina C; Zanardi E; Boccardo F
    Clin Genitourin Cancer; 2019 Aug; 17(4):e724-e732. PubMed ID: 31160193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in women with early stage small cell carcinoma of the uterine cervix.
    Huang CY; Chen YL; Chu TC; Cheng WF; Hsieh CY; Lin MC
    Oncol Res; 2009; 18(5-6):279-86. PubMed ID: 20225765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy.
    Chang TC; Lai CH; Tseng CJ; Hsueh S; Huang KG; Chou HH
    Cancer; 1998 Aug; 83(4):712-8. PubMed ID: 9708935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and outcomes of early-stage small cell neuroendocrine carcinoma of the cervix: 37 cases from a single center.
    Zhang D; Ma X
    PeerJ; 2019; 7():e6868. PubMed ID: 31110926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy.
    Li X; Yang R; Jia Y; Zhou J; Ma D; Li S
    Int J Gynaecol Obstet; 2015 Jul; 130(1):31-5. PubMed ID: 25890393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.
    Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
    BMC Cancer; 2014 Feb; 14():140. PubMed ID: 24575810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
    Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
    BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
    Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
    Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.